Literature DB >> 2433440

Orally and parenterally administered ibuprofen for postoperative adhesion prevention.

F D De Leon, J Odom, P Hudkins, R Vijayakumar, M W Heine.   

Abstract

Adhesion formation was examined in 45 rats that were divided into five groups of 9 animals each: control, oral ibuprofen, intramuscular ibuprofen, intraperitoneal 32% dextran 70, and oral ibuprofen plus intraperitoneal 32% dextran 70. Four weeks after receiving a standard injury, all the animals were killed and the adhesions scored blindly. Both the oral and intramuscular ibuprofen groups had significantly less severe adhesion formation (P less than .01) when compared to the control group. Although 32% dextran 70 alone showed no beneficial effect in reducing adhesions, the combination of oral ibuprofen and 32% dextran 70 had the least adhesion formation (P less than .002) when compared to the control group. Oral and intramuscular ibuprofen seem to be equally efficient in reducing postoperative adhesions. Furthermore, the combination of oral ibuprofen and 32% dextran 70 appears to have a synergistic effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433440

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Effects of non-steroidal anti-inflammatory drugs on flexor tendon rehabilitation after repair.

Authors:  Alireza Rouhani; Ali Tabrizi; Ehsan Ghavidel
Journal:  Arch Bone Jt Surg       Date:  2013-09-15

Review 2.  Ibuprofen in acute-care therapy.

Authors:  W B Rockwell; H P Ehrlich
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

3.  Effect of reactive oxygen species scavengers, antiinflammatory drugs, and calcium-channel blockers on carbon dioxide pneumoperitoneum-enhanced adhesions in a laparoscopic mouse model.

Authors:  M M Binda; C R Molinas; A Bastidas; P R Koninckx
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 3.453

4.  Management of complications in surgery of the colon.

Authors:  M Gmeiner; J Pfeifer
Journal:  Eur Surg       Date:  2007       Impact factor: 0.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.